If you can't see a significant progress curve in the past 2 of 7 years, you should definitely move on. The Vermillion test FDA approval alone sets HDC apart from the 1000's of med/bio-tech speculative companies out there with comparable or worse share structures and no confirmation of success beyond their own labs.
This board was moaning for an update and now we have it. The books are getting cleaned up, the team is assembled, the pipeline is shuffling along nicely.
With the urine based test, you have to realize how pervasive it's going to be. It must be absolutely as air tight as possible so that it can establish itself and then continue as the industry standard for prostate cancer testing.
It's Sept and the markets suck. After 7 years, what's a few more months IMO?
News 
Market Data 
Discover 
